{"schema_version":"1","generated_at":"2026-10-28T06:04:21.350Z","data_as_of":null,"url":"https://www.findmykol.com/kol/khalid-matin","json_url":"https://www.findmykol.com/kol/khalid-matin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"khalid-matin","name":"Khalid Matin","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Virginia Commonwealth University","institution_url":"https://www.findmykol.com/institution/virginia-commonwealth-university","city":"Richmond","state":"VA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1952375891","orcid":"0000-0001-5368-052X","openalex":"A5038221606"},"summary":"Khalid Matin is an Oncology physician affiliated with Virginia Commonwealth University. OpenAlex indexes 48 publications with 895 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":48,"cited_by_count":895,"h_index":14,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04643366","title":"Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Virginia Commonwealth University","source_url":"https://clinicaltrials.gov/study/NCT04643366","trial_url":"https://www.findmykol.com/trial/NCT04643366"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Amgen Inc.","program_year":2025,"amount_usd":4116,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952375891"},{"payer":"GlaxoSmithKline, LLC.","program_year":2025,"amount_usd":2967,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952375891"},{"payer":"Intera Oncology, Inc","program_year":2025,"amount_usd":219.6,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952375891"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1952375891","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":40,"classes_total":3,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":19.2,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":34},{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":12.4,"drugs":[{"name":"Creon","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":32.4,"classes_total":3,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":21.6,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":36},{"class":"Opioid Agonist","setting":"prescribed","share_pct":6.4,"drugs":[{"name":"Oxycodone Hcl","share_pct":100}],"max_beneficiaries":14}]},{"area":"Cancer & immunology","share_pct":12,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":12,"drugs":[{"name":"Sunitinib Malate","share_pct":60},{"name":"Everolimus","share_pct":40}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":20.5,"facility_pct":79.5},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2019,"last":2026},"rows_total":8,"shown":3,"withheld":5,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"UG1CA189869","title":"VCU Massey Comprehensive Cancer Center NCI Community Oncology Research Program","fiscal_year":2026,"amount_usd":"1351584","organization":"VIRGINIA COMMONWEALTH UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/UG1CA189869"},{"project":"UG1CA189869","title":"VCU Massey Comprehensive Cancer Center NCI Community Oncology Research Program","fiscal_year":2025,"amount_usd":"1239982","organization":"VIRGINIA COMMONWEALTH UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/UG1CA189869"},{"project":"UG1CA189869","title":"VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program","fiscal_year":2024,"amount_usd":"1189949","organization":"VIRGINIA COMMONWEALTH UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/UG1CA189869"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer","year":2026,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2507874","status":"verified"},{"title":"Health-related quality of life (HRQOL) in the phase 3 trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502, ATOMIC).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.3626","status":"verified"},{"title":"Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.17_suppl.lba1","status":"verified"},{"title":"752P Clinical outcome of patients (pts) with sporadic vs Lynch syndrome-related stage III colon carcinoma (CC) with deficient mismatch repair (dMMR) treated in a randomized trial of adjuvant FOLFOX alone or combined with atezolizumab (atezo; anti-PD-L1)","year":2025,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1016/j.annonc.2025.08.1325","status":"verified"},{"title":"Analysis of NCI Community Oncology Research Program (NCORP) clinical trial accrual rates in a comprehensive cancer center and its community affiliate sites.","year":2025,"journal":"JCO Oncology Practice","source_url":"https://doi.org/10.1200/op.2025.21.10_suppl.272","status":"verified"}],"source":"works"},"contact":{"address_1":"1250 E MARSHALL ST","address_2":"DEPT. OF INTERNAL MEDICINE-HEMATOLOGY/ONCOLOGY","city":"Richmond","state":"VA","zip":"232985051","phone":"804-828-7999","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1952375891","source":"identity"},"similar":[{"name":"Jasmohan Bajaj","slug":"jasmohan-bajaj","institution":"Virginia Commonwealth University","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/jasmohan-bajaj","json_url":"https://www.findmykol.com/kol/jasmohan-bajaj/profile.json"},{"name":"Patrick Ching","slug":"patrick-ching","institution":"Virginia Commonwealth University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/patrick-ching","json_url":"https://www.findmykol.com/kol/patrick-ching/profile.json"},{"name":"Bruce Rubin","slug":"bruce-rubin","institution":"Virginia Commonwealth University","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/bruce-rubin","json_url":"https://www.findmykol.com/kol/bruce-rubin/profile.json"},{"name":"Arehzo Jahangiri","slug":"arehzo-jahangiri","institution":"Virginia Commonwealth University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/arehzo-jahangiri","json_url":"https://www.findmykol.com/kol/arehzo-jahangiri/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":6,"funding":5,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-08-14","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}